Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics
about
In vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureusTherapeutic effects of imipenem-cilastatin on experimental intrauterine infections in rats.Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infectionsStability of imipenem in Mueller-Hinton agar stored at 4 degrees CImipenem pharmacokinetics and body fluid concentrations in patients receiving high-dose treatment for serious infections.Imipenem therapy of Pseudomonas aeruginosa and other serious bacterial infections.In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents.In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus sppN-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteriaComparative activities of 13 beta-lactam antibioticsSubinhibitory concentrations of imipenem induce increased resistance to methicillin and imipenem in vitro in methicillin-resistant Staphylococcus aureus.Effects of beta-lactam antibiotics on peptidoglycan synthesis in growing Neisseria gonorrhoeae, including changes in the degree of O-acetylation.Effects of hyperbaric oxygen on Pseudomonas aeruginosa susceptibility to imipenem and macrophages.Enhanced phagocytosis, killing, and serum sensitivity of Escherichia coli and Staphylococcus aureus treated with sub-MICs of imipenem.Determination of imipenem and cilastatin in serum by high-pressure liquid chromatography.Pharmacokinetics of imipenem-cilastatin in neonates.Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosisIn vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteriaN-formimidoyl thienamycin (MK0787): in vitro study.In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidimeSusceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.In vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone.In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.Superior activity of N-formimidoyl thienamycin against gentamicin-resistant Pseudomonas aeruginosa.In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agents.Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods.Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics.In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity.In vitro activity of imipenem--a review.Antibiotic resistance in pathogenic and producing bacteria, with special reference to beta-lactam antibiotics.Effect of imipenem-cilastatin therapy on fecal flora.In vitro activity of tebipenem, a new oral carbapenem antibiotic, against penicillin-nonsusceptible Streptococcus pneumoniae.Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia.Importance of position 170 in the inhibition of GES-type β-lactamases by clavulanic acid.Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN12873.Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.Effects of azlocillin in combination with clavulanic acid, sulbactam, and N-formimidoyl thienamycin against beta-lactamase-producing, carbenicillin-resistant Pseudomonas aeruginosa.A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.Comparative activities of N-formimidoyl thienamycin, ticarcillin, and tobramycin against experimental Pseudomonas aeruginosa pneumonia.
P2860
Q30451373-530A71DB-74E6-48EE-A11C-28927839DCE8Q35538772-66B0DE5F-C0A6-486D-98C9-8A66BA934224Q35542198-E70411B2-BE3D-48F4-9AA9-003284676321Q35572800-79075C80-B77F-471B-B060-C1B64889110BQ35573030-E356E100-3B38-432D-AF1A-C3848A8767B4Q35640457-010B49DF-8B1D-40DB-B2A6-CDE70B8368C8Q35646255-B0ECF1E9-D080-4EE4-B794-33019C6E9EE1Q35668463-CC958001-D6BD-4749-84FC-5458E3861E85Q35673370-72C92597-2FD2-4AD3-AACE-73568B7DEA8EQ35676188-2169456C-9F63-45BF-815C-184B184AB4ACQ35759130-D070E648-0996-4B3D-9B9F-3C9D67806A5EQ36630149-DF9D243C-F0E1-4D77-BBF6-83961976C5D2Q39037967-94C3475E-8A61-4C58-909D-DA40BD9C3584Q39818487-AE9C0C29-CBAE-4B58-878B-E318D3C9E1E3Q39848938-BDF0A9C8-2599-4673-A33E-FEB6B7FCE38DQ39849539-4D6A0D57-AD1B-42B0-90A3-CA10395790F1Q39849680-79C26BB6-45C6-42EF-AD31-3EB72F2499B0Q39849873-CFB0D83D-89FB-4BEC-8D65-10DF26ECCCF8Q39854470-16F87D70-A7C0-43BC-96D2-64D2ABB665D6Q39854704-43BE1906-C783-43FC-8DD5-EABEECF849D6Q39855023-298F1DBA-C650-4290-8082-F5C0FF42AC8CQ39855480-6B1F97D7-E183-4574-AD7D-0EBCA89B5B02Q39855832-26792F9C-F967-4205-AD85-1EA7A3BB0AF1Q39856082-50A295B7-0F54-46D6-9B1D-D5681BC2263EQ39856253-9B0295C3-C878-44F6-A2E2-2402E9AD63D2Q39856399-ACA056FE-F5FD-46E9-8273-70918974BF22Q39856904-0DBAA856-084A-47D1-A30B-A116A62D3732Q39857331-5C66CCEC-50F8-422C-ABC8-A5361A12A114Q39883853-D508F664-3819-4806-AA9A-3EFD947004C8Q40192467-62E9EBC2-3BF5-4D8B-803C-5183E4109B3BQ40270998-2FCE5FD6-007A-4ABB-B760-46907B5969F8Q40283458-8D177741-7A89-4503-81BF-E972C93C955BQ41091720-00E10029-5D76-464C-AAB3-6F6F1B8EB21DQ42008775-6495BC60-5A42-4D47-9817-93614942E519Q42111116-B97AF8F7-015C-4424-A546-E170B480B0CCQ42115499-A48EB980-CA09-4FD7-B264-9873CD7E0E6EQ42115513-356891A8-36EF-494C-9403-04F169A05ABDQ42175597-6D1FA25E-D0ED-44C7-BB94-C1F31890D20BQ42926832-2A107A78-58C3-47A7-8955-605C24A40B63Q42926899-EEB72C57-C54E-46BC-8FC6-A5F40B8C8547
P2860
Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics
description
1980 nî lūn-bûn
@nan
1980 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Antibacterial activities of a ...... parison with other antibiotics
@ast
Antibacterial activities of a ...... parison with other antibiotics
@en
Antibacterial activities of a ...... parison with other antibiotics
@nl
type
label
Antibacterial activities of a ...... parison with other antibiotics
@ast
Antibacterial activities of a ...... parison with other antibiotics
@en
Antibacterial activities of a ...... parison with other antibiotics
@nl
prefLabel
Antibacterial activities of a ...... parison with other antibiotics
@ast
Antibacterial activities of a ...... parison with other antibiotics
@en
Antibacterial activities of a ...... parison with other antibiotics
@nl
P2093
P2860
P356
P1476
Antibacterial activities of a ...... parison with other antibiotics
@en
P2093
P2860
P356
10.1128/AAC.17.6.912
P407
P577
1980-06-01T00:00:00Z